• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌术后放疗结局的影响因素分析

An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.

作者信息

Parsons J T, Mendenhall W M, Stringer S P, Cassisi N J, Million R R

机构信息

Department of Radiation Oncology, University of Florida College of Medicine, Gainesville 32610, USA.

出版信息

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):137-48. doi: 10.1016/s0360-3016(97)00152-1.

DOI:10.1016/s0360-3016(97)00152-1
PMID:9300748
Abstract

PURPOSE

To analyze factors influencing outcome in patients who received postoperative irradiation for advanced squamous cell carcinoma of the oral cavity.

METHODS AND MATERIALS

Between October 1964 and November 1993, 134 patients with 135 previously untreated primary invasive squamous cell carcinomas of the oral cavity (excluding the lip) were treated postoperatively with continuous courses of external-beam irradiation at the University of Florida. All patients had a minimum follow-up of 2 years (analysis, December 1995). No patient was lost to follow-up.

RESULTS

The 10-year actuarial rates of primary site, neck, and local-regional control were 79%, 88%, and 71%, respectively. Recurrence of cancer above the clavicles developed in 35 patients. Ninety-four percent of the recurrences were within the primary field of irradiation (anterior to the plane of the spinal cord); there were 24 recurrences at the primary site and nine in the upper neck alone. There were no failures in the neck area behind the plane of the spinal cord (i.e., the "posterior strip"). Two failures occurred in the low neck below the level of the thyroid notch. In univariate analyses, factors that affected local-regional control included pathologic stage (I-II vs. III-IV, p = 0.04), margin status (invasive cancer at the margin vs. other, p = 0.0007), multifocal tumor (p = 0.05), perineural invasion (p = 0.04), and number of indications for postoperative irradiation (p = 0.05). Extracapsular nodal extension was marginally significant (p = 0.07). In multivariate analysis, positive margins and number of indications remained significant. These factors were used to define relatively favorable (< 4 indications, margins not positive) and unfavorable (> or = 4 indications and/or margins positive for invasive cancer) groups. For both favorable and unfavorable groups, there were nonsignificant trends toward improved local-regional control for patients who began irradiation within 45-50 days, compared with those whose irradiation began later. There were also nonsignificant trends toward improved control for patients treated with shorter overall irradiation treatment courses. An analysis was also performed on the effects of duration of the overall "treatment package" (from the date of surgery until the last day of irradiation). For patients with unfavorable tumors, there was a significantly higher probability of local-regional control for patients whose overall "treatment package" was < or = 100 days (60% vs. 14%, p = 0.04). The 5-year rate of distant metastasis as the sole site of failure was 8% and was predicted by pathologic N stage (N0-N1, 3%; N2-N3, 16%, p = 0.02), as well as the presence (20%) or absence (6%) of extracapsular nodal extension (p = 0.06). The 5-year freedom-from-relapse rate was 63%. The 5-year survival and cause-specific survival rates were 50% and 67%, respectively. Four severe radiation injuries occurred (3%).

CONCLUSION

This paper provides data that define relatively favorable and unfavorable groups of patients in the postoperative setting. Patients with four or more indications for irradiation and/or invasive cancer at the surgical margins have a worse outcome than patients who do not have these negative factors; this is true in spite of the fact that the unfavorable group received higher doses of radiation. Attention should be focused on not only the interval between surgery and irradiation, but also time-dose parameters and the overall duration of the treatment "package."

摘要

目的

分析影响口腔晚期鳞状细胞癌患者术后放疗疗效的因素。

方法与材料

1964年10月至1993年11月期间,佛罗里达大学对134例患者的135例未经治疗的原发性口腔浸润性鳞状细胞癌(不包括唇部)进行了术后连续外照射治疗。所有患者的随访时间至少为2年(分析时间为1995年12月)。无患者失访。

结果

原发部位、颈部及局部区域控制的10年精算率分别为79%、88%和71%。35例患者出现锁骨上区癌症复发。94%的复发发生在放射野内(脊髓平面之前);原发部位复发24例,仅上颈部复发9例。脊髓平面后方的颈部区域无复发(即“后条带”)。甲状腺切迹以下的下颈部有2例复发。单因素分析中,影响局部区域控制的因素包括病理分期(I-II期与III-IV期,p = 0.04)、切缘状态(切缘有浸润癌与其他情况,p = 0.0007)、多灶性肿瘤(p = 0.05)、神经周围浸润(p = 0.04)以及术后放疗指征数量(p = 0.05)。包膜外淋巴结转移边缘显著(p = 0.07)。多因素分析中,切缘阳性和指征数量仍然显著。这些因素用于定义相对有利(< 4个指征,切缘阴性)和不利(≥ 4个指征和/或切缘有浸润癌阳性)组。对于有利组和不利组,与放疗开始较晚的患者相比,放疗在45 - 50天内开始的患者局部区域控制有改善的非显著趋势。总体放疗疗程较短的患者控制改善也有非显著趋势。还对整个“治疗包”(从手术日期至放疗最后一天)的持续时间的影响进行了分析。对于肿瘤不利的患者,整个“治疗包”≤ 100天的患者局部区域控制概率显著更高(60%对14%,p = 0.04)。远处转移作为唯一失败部位的5年发生率为8%,由病理N分期(N0 - N1,3%;N2 - N3,16%,p = 0.02)以及包膜外淋巴结转移的存在(20%)或不存在(6%)预测(p = 0.06)。5年无复发生存率为63%。5年生存率和病因特异性生存率分别为50%和67%。发生4例严重放射损伤(3%)。

结论

本文提供的数据定义了术后相对有利和不利的患者组。有4个或更多放疗指征和/或手术切缘有浸润癌的患者比没有这些不利因素的患者预后更差;尽管不利组接受了更高剂量的放疗,但情况依然如此。不仅应关注手术与放疗之间的间隔,还应关注时间 - 剂量参数和整个治疗“包”的持续时间。

相似文献

1
An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.口腔鳞状细胞癌术后放疗结局的影响因素分析
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):137-48. doi: 10.1016/s0360-3016(97)00152-1.
2
Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications.头颈部鳞状细胞癌的术后放疗:治疗结果与并发症分析
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):25-36. doi: 10.1016/0360-3016(89)90006-0.
3
Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience.口腔鳞状细胞癌的术后放疗:35年经验
Head Neck. 2004 Nov;26(11):984-94. doi: 10.1002/hed.20091.
4
Radiation therapy for squamous cell carcinoma of the supraglottic larynx.声门上型喉鳞状细胞癌的放射治疗
Am J Clin Oncol. 1989 Feb;12(1):17-23. doi: 10.1097/00000421-198902000-00005.
5
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.一项前瞻性随机试验的最终报告,该试验旨在评估头颈部癌患者术后放射治疗的剂量反应关系及病理风险组。
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1002-1011. doi: 10.1016/j.ijrobp.2017.02.218. Epub 2017 Jul 10.
6
Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas.头颈部鳞状细胞癌术后放疗患者的时间-剂量-反应关系
Radiother Oncol. 2001 Aug;60(2):137-45. doi: 10.1016/s0167-8140(01)00381-4.
7
Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome.口腔癌术后放疗:解剖亚部位对治疗结果的影响。
Head Neck. 1990 Nov-Dec;12(6):470-5. doi: 10.1002/hed.2880120604.
8
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.头颈部癌术后放射治疗剂量评估:一项前瞻性随机试验的首次报告
Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):3-11. doi: 10.1016/0360-3016(93)90167-t.
9
Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.同侧野照射在口腔和口咽癌原发手术后放疗中的应用。
Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):682-8. doi: 10.1016/j.ijrobp.2009.08.042. Epub 2010 Feb 25.
10
Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.对于切缘接近或阳性的口腔舌部和口底T1-2 N0鳞状细胞癌,单纯术后近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):37-42. doi: 10.1016/s0360-3016(00)00538-1.

引用本文的文献

1
Prospective Registry Trial of Adjuvant High-Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20-Year Data.未接受过放疗的头颈癌辅助高剂量率近距离放疗前瞻性注册试验:20年数据
Head Neck. 2025 Aug;47(8):2166-2173. doi: 10.1002/hed.28131. Epub 2025 Mar 10.
2
Delayed Postoperative Radiotherapy in Head & Neck Cancers-A Systematic Review and Meta-Analysis.头颈部癌症术后延迟放疗的系统评价与Meta分析
Laryngoscope. 2025 May;135(5):1563-1570. doi: 10.1002/lary.31990. Epub 2025 Jan 2.
3
[On the relevance of histopathology results in oropharyngeal cancer with mandibular involvement and the necessary imaging].
[关于组织病理学结果在伴有下颌骨受累的口咽癌中的相关性及必要的影像学检查]
HNO. 2025 Jan;73(1):60-66. doi: 10.1007/s00106-024-01519-7. Epub 2024 Oct 25.
4
Perineural Invasion Is a Significant Prognostic Factor in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.神经周围浸润是口腔鳞状细胞癌的一个重要预后因素:一项系统评价和荟萃分析
Diagnostics (Basel). 2023 Oct 30;13(21):3339. doi: 10.3390/diagnostics13213339.
5
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma.Merkel 细胞癌术后延迟放疗后复发和疾病特异性死亡风险增加。
J Am Acad Dermatol. 2024 Feb;90(2):261-268. doi: 10.1016/j.jaad.2023.07.1047. Epub 2023 Sep 30.
6
Prognostic Value of Lymph Node Density in Node-Positive Oral Squamous Cell Carcinoma.淋巴结密度在淋巴结阳性口腔鳞状细胞癌中的预后价值
Indian J Surg Oncol. 2023 Jun;14(2):487-491. doi: 10.1007/s13193-021-01451-0. Epub 2021 Sep 10.
7
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.术后 PET/CT 提高了口腔鳞状细胞癌早期复发的检出率。
Oral Oncol. 2023 Jun;141:106400. doi: 10.1016/j.oraloncology.2023.106400. Epub 2023 Apr 24.
8
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals.优化切缘状态以改善口腔鳞状细胞癌患者的预后:来自台湾两所最高手术量医院的回顾性研究。
Front Oncol. 2022 Nov 14;12:1019555. doi: 10.3389/fonc.2022.1019555. eCollection 2022.
9
A single-arm feasibility phase II study of EMF (erlotinib + methotrexate + 5-fluorouracil) regimen in platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).一项关于EMF(厄洛替尼+甲氨蝶呤+5-氟尿嘧啶)方案用于铂类难治性复发/转移性头颈部鳞状细胞癌(R/M HNSCC)的单臂可行性II期研究。
Ecancermedicalscience. 2022 Sep 29;16:1451. doi: 10.3332/ecancer.2022.1451. eCollection 2022.
10
Traditional risk factors and nodal yield-still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?传统危险因素和淋巴结转移——与高质量风险适应性辅助治疗局部晚期头颈部癌症仍相关?
Strahlenther Onkol. 2023 Mar;199(3):284-292. doi: 10.1007/s00066-022-02017-x. Epub 2022 Nov 9.